{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T20:59:14Z","timestamp":1774731554729,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.breast.2025.104645","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:34:28Z","timestamp":1763346868000},"page":"104645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7159-2149","authenticated-orcid":false,"given":"L.P.","family":"Jansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.G.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.W. van der","family":"Zee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"van de Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Adank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.F.D.","family":"Vrancken Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.K.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Drukker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2025.104645_bib1","unstructured":"Integraal kankercentrum Nederland Borstkanker in Nederland."},{"key":"10.1016\/j.breast.2025.104645_bib2","unstructured":"BorstkankerNABONRichtlijnendatabase https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/screening\/screening_buiten_het_bvo\/risicofactoren.html."},{"issue":"3","key":"10.1016\/j.breast.2025.104645_bib17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","article-title":"Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers","volume":"177","author":"Heemskerk-Gerritsen","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2025.104645_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"issue":"45","key":"10.1016\/j.breast.2025.104645_bib9","article-title":"CHEK2 mutation in Dutch breast cancer families: expanding genetic testing for breast cancer","volume":"159","author":"Adank","year":"2015","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"12","key":"10.1016\/j.breast.2025.104645_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/jmedgenet-2011-100380","article-title":"CHEK2\u22171100delC homozygosity is associated with a high breast cancer risk in women","volume":"48","author":"Adank","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.breast.2025.104645_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2023.103611","article-title":"The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families","volume":"73","author":"Schreurs","year":"2024","journal-title":"Breast"},{"issue":"9","key":"10.1016\/j.breast.2025.104645_bib52","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41436-021-01198-7","article-title":"The predictive ability of the 313-variant\u2013based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant","volume":"23","author":"Lakeman","year":"2021","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.breast.2025.104645_bib4","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee","year":"2019","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.breast.2025.104645_bib13","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1200\/JCO.22.01978","article-title":"Associations of a breast cancer polygenic risk score with tumor characteristics and survival","volume":"41","author":"Lopes Cardozo","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104645_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-82654-x","article-title":"The Angelina Jolie effect: contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer","volume":"11","author":"Basu","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.breast.2025.104645_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","article-title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation","volume":"121","author":"Metcalfe","year":"2019","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.breast.2025.104645_bib18","article-title":"Risk-reducing mastectomy for the prevention of primary breast cancer","volume":"2018","author":"Carbine","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.breast.2025.104645_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejca.2022.11.036","article-title":"EBCC-13 manifesto: balancing pros and cons for contralateral prophylactic mastectomy","volume":"181","author":"Schmidt","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2025.104645_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41416-023-02296-w","article-title":"Risk-reducing surgery for individuals with cancer-predisposing germline pathogenic variants and no personal cancer history: a review of current UK guidelines","volume":"129","author":"McCarthy","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2025.104645_bib21","series-title":"Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (NICE Clinical Guideline No. 164)","year":"2019"},{"issue":"1","key":"10.1016\/j.breast.2025.104645_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.breast.2025.104645_bib6","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"BRCA1 and BRCA2 cohort consortium. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2025.104645_bib50","author":"Kramer"},{"issue":"3","key":"10.1016\/j.breast.2025.104645_bib38","first-page":"48","article-title":"Bilateral risk-reducing mastectomy\u2014surgical procedure, complications and financial benefit","volume":"93","author":"Gierej","year":"2021","journal-title":"Pol J Surg"},{"issue":"12","key":"10.1016\/j.breast.2025.104645_bib39","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamasurg.2018.2493","article-title":"Breast cancer surgical risk reduction for patients with inherited mutations in moderate penetrance genes","volume":"153","author":"Weiss","year":"2018","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.breast.2025.104645_bib48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-017-4476-1","article-title":"The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy","volume":"167","author":"Giannakeas","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2025.104645_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10549-019-05440-4","article-title":"Risk-reducing mastectomy in BRCA carriers: survival is not the issue","volume":"179","author":"Neven","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2025.104645_bib54","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/curroncol31010023","article-title":"Counseling framework for germline BRCA1\/2 and PALB2 carriers considering risk-reducing mastectomy","volume":"31","author":"Wong","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.breast.2025.104645_bib36","article-title":"Patient-reported outcomes in bilateral prophylactic mastectomy with breast reconstruction: a narrative review","volume":"73","author":"Ticha","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.breast.2025.104645_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.815498","article-title":"Long-term patient satisfaction and quality of life following breast reconstruction using the BREAST-Q: a prospective cohort study","volume":"12","author":"Shiraishi","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.breast.2025.104645_bib49","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1245\/s10434-024-16484-2","article-title":"Society of surgical oncology breast disease site working group statement on bilateral risk-reducing mastectomy: indications, outcomes, and risks","volume":"32","author":"Singh","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.breast.2025.104645_bib35","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.ejca.2013.04.025","article-title":"International variation in physicians' attitudes toward prophylactic mastectomy: Comparison between France, Germany, the Netherlands and the United Kingdom","volume":"49","author":"den Heijer","year":"2013","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.breast.2025.104645_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/ajm.AJM_21_18","article-title":"Prophylactic mastectomy for the prevention of breast cancer: review of the literature","volume":"8","author":"Alaofi","year":"2018","journal-title":"Avicenna J Med"},{"issue":"6","key":"10.1016\/j.breast.2025.104645_bib25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11136-015-1181-6","article-title":"Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes","volume":"25","author":"Razdan","year":"2016","journal-title":"Qual Life Res"},{"key":"10.1016\/j.breast.2025.104645_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/PPA.S303208","article-title":"Quality of life after bilateral risk-reducing mastectomy and simultaneous reconstruction using pre-pectoral silicone implants","volume":"15","author":"Spindler","year":"2021","journal-title":"Patient Prefer Adherence"},{"issue":"9","key":"10.1016\/j.breast.2025.104645_bib27","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1245\/s10434-017-5915-2","article-title":"Impact of bilateral prophylactic mastectomy and immediate reconstruction on health-related quality of life in women at high risk for breast carcinoma: results of the mastectomy reconstruction outcomes consortium study","volume":"24","author":"McCarthy","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"24","key":"10.1016\/j.breast.2025.104645_bib45","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1200\/JCO.2007.13.9568","article-title":"Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study","volume":"26","author":"Brandberg","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.breast.2025.104645_bib46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.breast.2010.05.003","article-title":"Bilateral prophylactic mastectomy in women with inherited risk of breast cancer\u2013prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery","volume":"19","author":"Gahm","year":"2010","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.breast.2025.104645_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81052-3","article-title":"Evaluation of the integration of retrieval-augmented generation in large language model for breast cancer nursing care responses","volume":"14","author":"Xu","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.breast.2025.104645_bib57","doi-asserted-by":"crossref","DOI":"10.2196\/68426","article-title":"Evaluating a chatbot as a companion for patients with breast cancer: collaborative pilot study","volume":"11","author":"Boie","year":"2025","journal-title":"JMIR Cancer"},{"issue":"1","key":"10.1016\/j.breast.2025.104645_bib58","first-page":"e144","volume":"277","author":"Pfob","year":"2021","journal-title":"Towards patient-centered decision-making in breast cancer surgery Ann Surg"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625008628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625008628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:10:53Z","timestamp":1770999053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625008628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"alternative-id":["S0960977625008628"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104645","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104645"}}